Page last updated: 2024-10-21

enprofylline and Chronic Disease

enprofylline has been researched along with Chronic Disease in 1 studies

enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"A double-blind crossover study has been performed in 14 patients with moderately severe chronic asthma to compare the bronchodilator efficacy of two dosage regimens of intravenous enprofylline (high dose = 2 mg/kg bolus and 1 mg/kg/hour infusion; low dose = 1 mg/kg bolus and 500 micrograms/kg/hour infusion) with aminophylline (5 mg/kg/bolus and 500 micrograms/kg/hour infusion) and placebo."9.06Enprofylline in chronic asthma. ( Capewell, S; Chapman, BJ; Crompton, GK; Frame, MH; McDonald, C, 1988)
"A double-blind crossover study has been performed in 14 patients with moderately severe chronic asthma to compare the bronchodilator efficacy of two dosage regimens of intravenous enprofylline (high dose = 2 mg/kg bolus and 1 mg/kg/hour infusion; low dose = 1 mg/kg bolus and 500 micrograms/kg/hour infusion) with aminophylline (5 mg/kg/bolus and 500 micrograms/kg/hour infusion) and placebo."5.06Enprofylline in chronic asthma. ( Capewell, S; Chapman, BJ; Crompton, GK; Frame, MH; McDonald, C, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chapman, BJ1
McDonald, C1
Capewell, S1
Frame, MH1
Crompton, GK1

Trials

1 trial available for enprofylline and Chronic Disease

ArticleYear
Enprofylline in chronic asthma.
    British journal of diseases of the chest, 1988, Volume: 82, Issue:4

    Topics: Adult; Aged; Aminophylline; Asthma; Bronchodilator Agents; Chronic Disease; Clinical Trials as Topic

1988